Gene Sets With the Lowest 5 BMD Median Values Among the Significantly Enriched Gene Sets by Functional Classification Within BMD Analysis (Defined by p Value < .1 From Fisher’s Exact Two-Tailed Test Considering Significantly Dose-Responsive Genes as Determined by BMDExpress) for Each Tissue Compartment at Each Timepoint
Sialic acid metabolism
GO/Pathway/Gene Set/Gene Name . | Fisher’s Exact 2-Tailed . | BMD Median (mg/kg bw/day) . |
---|---|---|
Crypt—day 8 | ||
Eukaryotic Translation Elongation | 0.09 | 1.74 |
Chylomicron clearance | 0.09 | 2.51 |
Biosynthesis of maresins | 0.003 | 3.05 |
Mitochondrial translation elongation | 0.06 | 3.21 |
Mitochondrial translation termination | 0.07 | 3.21 |
Crypt—day 91 | ||
Chemokine receptors bind chemokines | 1.31E-04 | 1.60 |
Utilization of ketone bodies | 0.05 | 2.65 |
PERK [protein kinase R (PKR)-like endoplasmic reticulum kinase] regulates gene expression | 0.02 | 2.75 |
OAS [oligoadenylate synthetase] antiviral response | 0.01 | 2.78 |
Glutathione conjugation | 0.08 | 2.92 |
Villus—day 8 | ||
Pyrimidine catabolism | 0.04 | 1.34 |
Butyrophilin family interactions | 0.09 | 1.95 |
Gluconeogenesis | 0.04 | 2.64 |
Nucleotide salvage | 0.005 | 2.89 |
Eukaryotic Translation Elongation | 0.004 | 2.95 |
Villus—day 91 | ||
0.08 | 0.16 | |
HDMs demethylate histones | 0.01 | 0.62 |
Drug-mediated inhibition of ERBB2 signaling | 0.01 | 0.67 |
Nonhomologous end-joining | 0.002 | 0.67 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.06 | 0.67 |
GO/Pathway/Gene Set/Gene Name . | Fisher’s Exact 2-Tailed . | BMD Median (mg/kg bw/day) . |
---|---|---|
Crypt—day 8 | ||
Eukaryotic Translation Elongation | 0.09 | 1.74 |
Chylomicron clearance | 0.09 | 2.51 |
Biosynthesis of maresins | 0.003 | 3.05 |
Mitochondrial translation elongation | 0.06 | 3.21 |
Mitochondrial translation termination | 0.07 | 3.21 |
Crypt—day 91 | ||
Chemokine receptors bind chemokines | 1.31E-04 | 1.60 |
Utilization of ketone bodies | 0.05 | 2.65 |
PERK [protein kinase R (PKR)-like endoplasmic reticulum kinase] regulates gene expression | 0.02 | 2.75 |
OAS [oligoadenylate synthetase] antiviral response | 0.01 | 2.78 |
Glutathione conjugation | 0.08 | 2.92 |
Villus—day 8 | ||
Pyrimidine catabolism | 0.04 | 1.34 |
Butyrophilin family interactions | 0.09 | 1.95 |
Gluconeogenesis | 0.04 | 2.64 |
Nucleotide salvage | 0.005 | 2.89 |
Eukaryotic Translation Elongation | 0.004 | 2.95 |
Villus—day 91 | ||
0.08 | 0.16 | |
HDMs demethylate histones | 0.01 | 0.62 |
Drug-mediated inhibition of ERBB2 signaling | 0.01 | 0.67 |
Nonhomologous end-joining | 0.002 | 0.67 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.06 | 0.67 |
Gene Sets With the Lowest 5 BMD Median Values Among the Significantly Enriched Gene Sets by Functional Classification Within BMD Analysis (Defined by p Value < .1 From Fisher’s Exact Two-Tailed Test Considering Significantly Dose-Responsive Genes as Determined by BMDExpress) for Each Tissue Compartment at Each Timepoint
Sialic acid metabolism
GO/Pathway/Gene Set/Gene Name . | Fisher’s Exact 2-Tailed . | BMD Median (mg/kg bw/day) . |
---|---|---|
Crypt—day 8 | ||
Eukaryotic Translation Elongation | 0.09 | 1.74 |
Chylomicron clearance | 0.09 | 2.51 |
Biosynthesis of maresins | 0.003 | 3.05 |
Mitochondrial translation elongation | 0.06 | 3.21 |
Mitochondrial translation termination | 0.07 | 3.21 |
Crypt—day 91 | ||
Chemokine receptors bind chemokines | 1.31E-04 | 1.60 |
Utilization of ketone bodies | 0.05 | 2.65 |
PERK [protein kinase R (PKR)-like endoplasmic reticulum kinase] regulates gene expression | 0.02 | 2.75 |
OAS [oligoadenylate synthetase] antiviral response | 0.01 | 2.78 |
Glutathione conjugation | 0.08 | 2.92 |
Villus—day 8 | ||
Pyrimidine catabolism | 0.04 | 1.34 |
Butyrophilin family interactions | 0.09 | 1.95 |
Gluconeogenesis | 0.04 | 2.64 |
Nucleotide salvage | 0.005 | 2.89 |
Eukaryotic Translation Elongation | 0.004 | 2.95 |
Villus—day 91 | ||
0.08 | 0.16 | |
HDMs demethylate histones | 0.01 | 0.62 |
Drug-mediated inhibition of ERBB2 signaling | 0.01 | 0.67 |
Nonhomologous end-joining | 0.002 | 0.67 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.06 | 0.67 |
GO/Pathway/Gene Set/Gene Name . | Fisher’s Exact 2-Tailed . | BMD Median (mg/kg bw/day) . |
---|---|---|
Crypt—day 8 | ||
Eukaryotic Translation Elongation | 0.09 | 1.74 |
Chylomicron clearance | 0.09 | 2.51 |
Biosynthesis of maresins | 0.003 | 3.05 |
Mitochondrial translation elongation | 0.06 | 3.21 |
Mitochondrial translation termination | 0.07 | 3.21 |
Crypt—day 91 | ||
Chemokine receptors bind chemokines | 1.31E-04 | 1.60 |
Utilization of ketone bodies | 0.05 | 2.65 |
PERK [protein kinase R (PKR)-like endoplasmic reticulum kinase] regulates gene expression | 0.02 | 2.75 |
OAS [oligoadenylate synthetase] antiviral response | 0.01 | 2.78 |
Glutathione conjugation | 0.08 | 2.92 |
Villus—day 8 | ||
Pyrimidine catabolism | 0.04 | 1.34 |
Butyrophilin family interactions | 0.09 | 1.95 |
Gluconeogenesis | 0.04 | 2.64 |
Nucleotide salvage | 0.005 | 2.89 |
Eukaryotic Translation Elongation | 0.004 | 2.95 |
Villus—day 91 | ||
0.08 | 0.16 | |
HDMs demethylate histones | 0.01 | 0.62 |
Drug-mediated inhibition of ERBB2 signaling | 0.01 | 0.67 |
Nonhomologous end-joining | 0.002 | 0.67 |
DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.06 | 0.67 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.